Companies

Evommune, Inc. (EVMN) SEC filings

CIK 0002044725 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025
Revenue (USD)13.0 M
Net income (USD)-68.9 M
Diluted EPS (USD/shares)-11.22

Latest filings

FiledFormDescriptionPeriod
2026-10-154PRIMARY DOCUMENT2026-09-30
2026-10-018-K8-K items 7.01,9.012026-10-01
2026-09-238-K8-K items 7.01,9.012026-09-23
2026-09-158-K8-K items 7.01,9.012026-09-15
2026-09-09424B3424B3
2026-09-098-K8-K items 7.01,8.01,9.012026-09-08
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-06424B3424B3
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-07-308-K8-K items 7.01,9.012026-07-29
2026-07-16SCHEDULE 13GSCHEDULE 13G
2026-07-104PRIMARY DOCUMENT2026-07-08
2026-07-084PRIMARY DOCUMENT2026-07-07
2026-06-29424B3424B3
2026-06-298-K8-K items 7.01,8.01,9.012026-06-29
2026-06-244PRIMARY DOCUMENT2026-06-22
2026-06-244PRIMARY DOCUMENT2026-06-22
2026-06-244PRIMARY DOCUMENT2026-06-22
2026-06-22144144
2026-06-034PRIMARY DOCUMENT2026-06-02
2026-06-034PRIMARY DOCUMENT2026-06-02
2026-06-034PRIMARY DOCUMENT2026-06-02
2026-06-034PRIMARY DOCUMENT2026-06-01

Forms on file (last 1,000): 4 50, 3 15, 8-K 15, 144 6, 424B3 6, SCHEDULE 13G 4, UPLOAD 4, D 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=EVMN (0.002 USD), /gw/filings/filings?ticker=EVMN&form=8-K, /gw/filings/facts?ticker=EVMN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange